Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company NanoCor Therapeutics Inc.
DescriptionProtein phosphatase 1 regulatory inhibitor subunit 1A (PPP1R1A) gene delivered via biological nanoparticles (BNP) technology
Molecular Target Protein phosphatase 1 regulatory inhibitor subunit 1A (PPP1R1A)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Adeno-associated virus (AAV)
Latest Stage of DevelopmentPreclinical
Standard IndicationCongestive heart failure (CHF)
Indication DetailsTreat congestive heart failure (CHF)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today